Table 3.
CPH (n = 13) | Placebo (n = 15) | |||||
---|---|---|---|---|---|---|
Inflammatory Marker | Baseline | End of Study | p-Value | Baseline | End of Study | p-Value |
iFABP (ng/mL) | 68.3 (43.2) | 58.2 (28.0) | 0.432 | 55.5 (20.1) | 56.2 (28.7) | 0.940 |
LBP (ng/mL) | 6097 (2630) | 6446 (2043) | 0.355 | 6931 (3023) | 6884 (3274) | 0.925 |
Zonulin (ng/mL) | 40.5 (5.6) | 42.5 (6.3) | 0.125 | 46.6 (5.9) | 45.7 (5.3) | 0.286 |
IL-8 (pg/mL) | 8.8 (11.8) | 11.4 (10.1) | 0.185 | 7.4 (6.5) | 8.9 (9.1) | 0.413 |
iFABP: Intestinal fatty acid binding protein, LBP: Lipopolysaccharide binding protein, IL: Interleukin.